BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4599859)

  • 1. Comparative clinical study of tobramycin and gentamicin.
    Klastersky J; Hensgens C; Henri A; Daneau D
    Antimicrob Agents Chemother; 1974 Feb; 5(2):133-8. PubMed ID: 4599859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of tobramycin and gentamicin].
    Klastersky J; Daneau D; Henri A
    Acta Clin Belg; 1972; 27(5):589-99. PubMed ID: 4205788
    [No Abstract]   [Full Text] [Related]  

  • 3. Emergence of gentamicin-resistant bacteria: experience with tobramycin therapy of infections due to gentamicin-resistant organisms.
    Moellering RC; Wennersten C; Kunz LJ
    J Infect Dis; 1976 Aug; 134 Suppl():S40-9. PubMed ID: 972284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy with carbenicillin and gentamicin for patients with cancer and severe infections caused by gram-negative rods.
    Klastersky J; Cappel R; Daneau D
    Cancer; 1973 Feb; 31(2):331-6. PubMed ID: 4569296
    [No Abstract]   [Full Text] [Related]  

  • 5. [Amikacin in the treatment of hospital infections of the urinary tract caused by gram-negative bacilli resistant to gentamicin. Microbiological and clinical aspects].
    Romoli E; Di Leonardo F; Giordano G; De Felice M; Cerquetti F; Vonmoos A
    Minerva Urol; 1981; 33(2):85-90. PubMed ID: 7322100
    [No Abstract]   [Full Text] [Related]  

  • 6. Tobramycin: clinical and microbiological evaluation.
    Schoutens E; Vanderlinden MP; Yourassowsky E
    Int J Clin Pharmacol; 1973 Nov; 8(3):207-15. PubMed ID: 4589328
    [No Abstract]   [Full Text] [Related]  

  • 7. Tobramycin in the treatment of severe and complicated urinary tract infections.
    Bailey RR; Peddie B
    N Z Med J; 1976 Jul; 84(567):1-3. PubMed ID: 823477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical comparison of tobramycin and gentamicin sulfate in the treatment of ocular infections.
    Laibson P; Michaud R; Smolin G; Okumoto M; Rosenthal A; Cagle G
    Am J Ophthalmol; 1981 Dec; 92(6):836-41. PubMed ID: 7032304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriological, clinical, and pharmacological investigations with tobramycin in patients with serious urinary tract infection.
    Iván E; Cstáry KN
    J Infect Dis; 1976 Aug; 134 Suppl():S153-5. PubMed ID: 823274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The aminoglycosides. Streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, sisomicin.
    Edson RS; Keys TF
    Mayo Clin Proc; 1983 Feb; 58(2):99-102. PubMed ID: 6823164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
    Scully BE; Neu HC
    Am J Med; 1985 Feb; 78(2):251-61. PubMed ID: 4038574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
    Watanakunakorn C; Kauffman CA
    Infection; 1978; 6(3):111-5. PubMed ID: 98451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, comparative study of tobramycin and gentamicin in treatment of acute urinary tract infections.
    Walker BD; Gentry LO
    J Infect Dis; 1976 Aug; 134 Suppl():S146-9. PubMed ID: 787449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive increase in antibiotic resistance of gram-negative bacterial isolates. Walter Reed Hospital, 1976 to 1980: specific analysis of gentamicin, tobramycin, and amikacin resistance.
    Cross AS; Opal S; Kopecko DJ
    Arch Intern Med; 1983 Nov; 143(11):2075-80. PubMed ID: 6639227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year surveillance of aminoglycoside usage in a university hospital.
    Betts RF; Valenti WM; Chapman SW; Chonmaitree T; Mowrer G; Pincus P; Messner M; Robertson R
    Ann Intern Med; 1984 Feb; 100(2):219-22. PubMed ID: 6691664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance of aminoglycoside resistance. European data.
    Van Landuyt HW; Boelaert J; Glibert B; Gordts B; Verbruggen AM
    Am J Med; 1986 Jun; 80(6B):76-81. PubMed ID: 3089007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of tobramycin on gentamicin-resistant strains in Pseudomonas keratitis.
    Smolin G; Okumoto M; Wilson FM
    Am J Ophthalmol; 1974 Apr; 77(4):583-8. PubMed ID: 4206621
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and laboratory study of tobramycin in the treatment of infections due to gram-negative organisms.
    Marrie TJ; Gurwith MJ; Ronald AR; Stiver HG; Lank B; Fox L
    Can Med Assoc J; 1977 Jul; 117(2):138-43. PubMed ID: 406032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical use of gentamicin in urinary tract infections due to Pseudomonas or Proteus].
    Shiba T; Ohashi N; Kamiya K; Fujieda J; Omuro H
    Hinyokika Kiyo; 1971 Sep; 17(9):601-4. PubMed ID: 5166131
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibiotic resistance patterns during aminoglycoside restriction.
    Young EJ; Sewell CM; Koza MA; Clarridge JE
    Am J Med Sci; 1985 Dec; 290(6):223-7. PubMed ID: 3936358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.